Hepcare 300 Tablet contains Ursodeoxycholic Acid 300 mg, a hydrophilic bile acid used primarily in the treatment of various hepatobiliary disorders. It is indicated for the dissolution of cholesterol gallstones in patients with a functioning gallbladder and for the management of primary biliary cholangitis (PBC), a chronic liver disease characterized by progressive destruction of intrahepatic bile ducts. Ursodeoxycholic Acid works by reducing cholesterol absorption and secretion, thereby decreasing cholesterol saturation in bile and promoting the gradual dissolution of gallstones. Additionally, it exerts cytoprotective effects on hepatocytes and cholangiocytes by stabilizing cell membranes and reducing bile acid-induced apoptosis. Hepcare 300 is also employed to improve liver function tests and delay disease progression in PBC patients. The recommended dosage and duration of therapy depend on the specific indication and patient response, and treatment should be guided by periodic monitoring of liver function and imaging studies. Common adverse effects include mild gastrointestinal disturbances such as diarrhea and nausea. Hepcare 300 should be used with caution in patients with biliary obstruction or acute cholecystitis. It is contraindicated in patients with hypersensitivity to Ursodeoxycholic Acid or its components. Always consult a healthcare professional before initiating therapy.